Cost-Effectiveness Study of Difamilast 1% for the Treatment of Atopic Dermatitis in Adult Japanese Patients

Cost-Effectiveness Study of Difamilast 1% for the Treatment of Atopic Dermatitis in Adult Japanese Patients

Abstract Introduction Difamilast has proven to be an effective treatment for the treatment of atopic dermatitis (AD) in Japan, but its cost-effectiveness remains unknown. Therefore, the objective of the current study was to determine the cost-effectiveness of difamilast 1% compared with delgocitinib...

Full description

Saved in:
Bibliographic Details
Main Authors: Takeshi Nakahara, Shinichi Noto, Miyuki Matsukawa, Hiroe Takeda, Yilong Zhang, Tomohiro Kondo
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-11-01
Series:Dermatology and Therapy
Subjects:
Atopic dermatitis
Incremental cost-effectiveness ratio
Difamilast
Delgocitinib
Japan
Online Access:https://doi.org/10.1007/s13555-024-01300-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items